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A 31-year-old woman with neurofibromatosis type I (NF-I) came to our hospital with hypotension and abdominal pain. A
computed tomography (CT) scan showed blood in the retroperitoneum and two saccular aneurysms in the superior mesenteric
artery (SMA). The largest measured 2.5 cm in diameter. She was treated with placement of a covered stent in the SMA, and
both aneurysms were excluded from the systemic circulation. Arterial aneurysms are rare in this disease, and rupture of an SMA
aneurysm in this context had been reported only once. We report an unusual case of a contained rupture of an SMA aneurysm
associated with NF-I, successfully treated with a covered stent. (J Vasc Surg 2010;51:461-4.)Neurofibromatosis type I (NF-I), or von Reckling-
hausen disease, is an autosomal dominant disorder affecting
one in 3000 individuals.1 Cardinal features of NF-I include
multiple café-au-lait macules, benign neurofibromas, and
iris hamartomas.1 Arterial involvement has also been noted,
usually in the form of stenoses. Aneurysms involving the
superior mesenteric artery (SMA) have been infrequently
reported, and rupture of an SMA aneurysm in this context
had been reported only once.2 We submit an unusual case
of a contained rupture of an SMA aneurysm in a patient
with NF-I, treated successfully with a covered stent.
CASE REPORT
A 31-year-old woman came to the emergency department of
our University Hospital with hypotension (90/60 mm Hg) and
abdominal pain. She had these symptoms for approximately 6
hours. The patient had been diagnosed in childhood with NF-I
when a benign neurofibroma was resected from her abdomen at
age 6. She hadmultiple café-au-lait skin macules and subcutaneous
neurofibromas in both legs. She had no history of diabetes melli-
tus, hypertension, or tobacco use. She denied any history of
previous abdominal trauma or intravenous drug abuse. She was not
taking any medications.
The emergency department doctor administered intravenous
fluids, and her blood pressure increased to 110/70 mm Hg; the
patient was alert, and her heart rate was 82 beats/minute. An
emergency computed tomography (CT) scan showed blood in the
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doi:10.1016/j.jvs.2009.08.039retroperitoneum (Fig 1) and two saccular aneurysms arising from
the SMA (Fig 2), without active bleeding. The largest measured 25
mm in diameter, and the second aneurysm measured 17 mm.
The patient was taken immediately to the angiography suite.
The right common femoral artery was punctured, and the SMA
was selectively catheterized with a 5F internal mammary catheter.
At this point, 3500 units of intravenous heparin were adminis-
tered. Angiography confirmed the presence of two saccular aneu-
rysms arising from the SMA (Fig 3), with no active bleeding at the
moment. The catheter was negotiated over a 0.035-inch guidewire
into the distal portion of the vessel. At that point, a 0.035-inch stiff
Rosen wire was advanced through the catheter, and the catheter
was removed. An 8F catheter sheath had been placed in the right
groin over the Rosen wire. Through the sheath, a 7F guiding
catheter was placed over the Rosen wire in the proximal portion of
the SMA. A polytetrafluoroethylene (PTFE)-covered stent (Ad-
vanta V12, 6  38 mm, Atrium Medical Corporation, Hudson,
NH) was advanced over the guidewire into the SMA. Arteriogra-
phy was then performed to find the best position for the covered
stent, and it was then inflated to 6 mm. After its placement, an
arteriography showed that both aneurysms were excluded from the
systemic circulation (Fig 4). At least three jejunal branches were
covered by the stent, but the patient did not have any symptoms of
bowel ischemia, because the collateral circulation was very good.
A follow-up CT scan (1 month after the procedure) showed
patency of the SMA, correct position of the stent, and confirmed the
exclusion of both aneurysms from the systemic circulation (Fig 5).
The patient made a full recovery, with no major adverse events
and was discharged 2 days postoperatively. At a 6-month review,
the duplex B-mode images did not show any turbulence or stenosis
proximal, intra, or distal to the covered stent. We did not see any
leaks (there was no flow inside the aneurysms). The fasting duplex
ultrasound scan peak systolic velocities were 184 cm/second in the
SMA proximal to the stent, 191 cm/second intra-stent, and 191
cm/second in the SMA distal to the stent.
DISCUSSION
Neurofibromatosis was first described by von Reckling-
hausen in 1882.3 It is an autosomal dominant inheritable
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ical hallmark of neurofibromatosis, and at least seven vari-
eties of the disease have been described, of which type I is
the most common.4
NF-I, also called von Recklinghausen disease, presents
with typical café-au-lait macules, benign neurofibromas,
and iris hamartomas.1,5 It has been shown that the gene
mutation in NF-I is located in the pericentric region of
Fig 1. Computed tomography (CT) scan showing blood in the
retroperitoneum.
Fig 2. Computed tomography (CT) scan showing two saccular
aneurysms arising from the superior mesenteric artery (SMA).chromosome 17.6-9The prognosis for neurofibromatosis, which is unpre-
dictable for a given subject, depends essentially on the
existence of cerebral tumors, which are responsible for
death in 72% of cases.10
Vascular involvement in NF-I has been systematically
described by Reubi11 in 1944. He described three forms of
vascular lesions, depending on the size of the vessel: pure
intimal, intimal-aneurysmal, and adventitial-nodular. He
noted intimal proliferation with breakdown of muscle and
elastic layers and adventitial nodular thickening. Feyrter12
subsequently described an epitheloid form, with involve-
ment of the entire vessel wall by neural cells. In 1974, Salyer
and Salyer13 proposed Schwann cell proliferation as the
common pathogenesis. That same year, Greene et al14
defined two different lesions based on vessel size. In larger
vessels, there was direct invasion by Schwann cells and
intimal thickening and destruction of the media and elastic
tissue, leading to either stenosis or aneurysm. In smaller
vessels, mesodermal dysplasia caused a proliferation of
smooth muscle in the intima resulting in stenotic lesions
and occasionally poststenotic aneurysms.
Arterial stenosis has been the most commonly reported
lesion. Cases of renal artery stenosis have been the most
frequent.14,15 Celiac, mesenteric, iliac, and intracranial ar-
tery stenoses have also been noted. Arterial aneurysms have
Fig 3. Selective angiography of the superior mesenteric artery
(SMA), demonstrating two saccular aneurysms in this vessel, be-
fore the implant of a covered stent.been less commonly described. These have often been
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involvement seems to predominate.2
Aneurysms of the visceral arteries are exceptional in this
disease; the major concern is the splenic artery.16 Only eight
cases of SMA aneurysms have been reported in NF-I.2,15-19
Zochodne15 reported a 2-cm diameter aneurysm of the
SMA associated with coarctation of the abdominal aorta
and poststenotic changes in the renal arteries. Fye et al16
described multiple small aneurysms on the branches of the
SMA. Henley and Kaude17 mentioned an SMA associated
with multiple renal artery aneurysms but did not detail the
case. Hassen-Khodja et al18 reported a case with two aneu-
rysmal defects: one on the common hepatic artery (treated
with embolization) and another on the SMA (not treated).
Huffman et al2 reported a patient who underwent ligation
of a ruptured SMA aneurysm. Finally, Cormier and
Cormier19 reported three cases: one involving only the
SMA and the two others associated with thoracoabdominal
coarctation. Our patient had two aneurysmal defects on the
SMA, presented with contained rupture, and underwent
successful endovascular repair.
The histopathologic features of arterial lesions in NF-I
disease consist of fibrodysplastic changes in the media with
segmental fragmentation of the vessel wall caused by atro-
phy of the muscularis and formation of saccular aneurysms.
Fig 4. Selective angiography of the superior mesenteric artery
(SMA) after the implant of a covered stent: both aneurysms were
excluded from the systemic circulation.Both aneurysms in our patient were of the saccular type.Fusiform aneurysms are less common and are often post-
stenotic.11,13,14
The pathophysiologic characteristics of vascular lesions
in neurofibromatosis remain controversial. The alterations
observed in the media and the adventitia appear compatible
with the mesodermic and neuroectodermic tissue involve-
ment in this disease.5,11,13,14
The silent nature of most vascular lesions and the
inaccessibility of involved vessels to clinical examination
have resulted in an underappreciation of its occurrence. An
autopsy series of NF-I patients who died from other causes
found vascular abnormalities in eight (44%) of 18 cases.13
Screening of all patients with NF-I for arterial disease
should be performed. Noninvasive imagingmodalities such
as duplex ultrasound scanning, magnetic resonance angiog-
raphy, and CT scanning are useful means of visualizing
vessels. Reports of involvement of almost every major artery
can be found in the literature, and no vessels are spared,
including veins.20
We decided to offer the endovascular treatment to our
patient because the origin of both aneurysms in the SMA
were very close, and a covered stent could exclude both
aneurysms from the systemic circulation at the same time.
In addition, the patient had a previous abdominal opera-
Fig 5. Follow-up computed tomography (CT) scan (1 month
after the procedure) showing patency of the superior mesenteric
artery (SMA), correct position of the stent, and exclusion of both
aneurysms from the systemic circulation.tion at age 6 to remove a neurofibroma very close to the
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should be avoided. Given the patient’s young age and the
long-term concerns of SMA stent stenosis/occlusion, we
recommend follow-up with duplex ultrasound scan at a
6-month interval and continuous use of aspirin and clopi-
dogrel. If a significant stenosis is found, the SMA stent
should undergo percutaneous transluminal angioplasty to
avoid occlusion and potential bowel ischemia. Because
histologic confirmation of the nature of the SMA aneu-
rysms was not obtained, their relationship to the patient’s
neurofibromatosis remains unproven, but it seems most
probable. To our knowledge, this is the first patient who
underwent successful endovascular repair of a contained
rupture of an SMA aneurysm resulting from NF-I.
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